Prognostic relevance of circulating cancer cells and immunosuppression in resectable pancreatic carcinoma
1. Introduction
Pancreatic adenocarcinoma is the fourth commonest cause of death from cancer in men and women, with 5-year survival for all stages of disease of less than 5%. The case-fatality